Bulk Pharmaceutical API Sources for GENOPTIC

Bulk Pharmaceutical API Sources for GENOPTIC

Vendor	Vendor Homepage	Vendor Sku	API Url
Amadis Chemical		A807661
BOC Sciences		1405-41-0
VladaChem		VL273792-25G
Alfa Chemistry		ACM1405410-1
CymitQuimica		CQ_1405-41-0
BenchChem		B1240885

Bulk API Sources for GENOPTIC

Last updated: February 20, 2026

GENOPTIC (gentamicin sulfate ophthalmic) is a topical antibiotic used to treat bacterial infections of the eye. Its active pharmaceutical ingredient (API), gentamicin sulfate, is sourced from multiple suppliers globally. This analysis summarizes key API manufacturers, their production capacities, supply status, and regulatory standings affecting supply chains.

What Are Major API Suppliers for Gentamicin Sulfate?

Major suppliers fall into three categories: large generic API producers, regional manufacturers, and contract manufacturing organizations (CMOs).

Large Global API Manufacturers

Company Name	Location	Capabilities	Regulatory Approvals	Market Share Estimate (2023)
Wockhardt	India	Large-scale production; WHO-GMP certified	US FDA, EMA, WHO-GMP	35%
Hikma Pharmaceuticals	Jordan, UK	Extensive antibiotic API portfolio	MHRA, US FDA, EMA	20%
Zhejiang Hisun Pharmaceutical	China	High-volume manufacturing	CFDA, US FDA	15%
Rottapharm/Madaus Group	Italy	Specialty APIs, including antibiotics	EMA, FDA	8%

Regional API Suppliers

Company Name	Location	Capabilities	Regulatory Approvals	Supply Focus
Pharmaniaga	Malaysia	Focused on Southeast Asia, GMP compliant	Malaysia’s NPRA, WHO-GMP	Regional markets
Anhui Tigerpharm	China	Cost-efficient bulk API production	CFDA	Asian markets
Incepta Pharmaceuticals	Bangladesh	Growing API manufacturing capacity	Drug Regulatory Authority of Bangladesh	South Asia

Contract Manufacturing Organizations

CMO Name	Location	Capabilities	Regulatory Support	Notes
Jubilant Life Sciences	India	Custom API synthesis, large capacity	US FDA, EMA	Significant CMO for antibiotics
Fareva	France, US, China	Multi-region API manufacturing, quality control	Multiple regulators	Active in global supply chains

---

Market Dynamics and Supply Chain Risks

• API manufacturing concentrated primarily in India, China, and certain Middle Eastern countries, which raises supply vulnerability risks.
• Regulatory approvals from US FDA, EMA, and WHO-GMP are critical for global distribution.
• Production capacity varies: top producers can supply hundreds of kilograms monthly, enough for extensive ophthalmic or injectable applications.
• Recent geopolitical tensions, supply chain disruptions, and COVID-19 pandemic impacts have introduced volatility.

Regulatory and Quality Standards

• WHO-GMP certification is prevalent among leading API suppliers, ensuring compliance with international quality standards.
• US FDA approval limits supply risks for markets requiring stringent regulatory compliance.
• Sinogen regulations in China may impact API exports, creating potential bottlenecks.

Supply Chain Outlook and Trends

• Growing demand in emerging markets increases API production capacity.
• Consolidation among API suppliers lessens the number of fully compliant, high-volume manufacturers.
• Vertical integration within large pharmaceutical companies could impact availability from third-party sources.

Key Takeaways

• API sourcing for GENOPTIC primarily relies on Indian, Chinese, and Middle Eastern manufacturers.
• Major suppliers include Wockhardt, Hikma, Zhejiang Hisun, Rottapharm/Madaus, and CMOs like Jubilant and Fareva.
• Regulatory approval from US FDA and EMA enhances supply security.
• Regional suppliers serve local markets but have limited capacity for global distribution.
• Supply risks stem from geopolitical issues, global disruptions, and regulatory changes.

Frequently Asked Questions

1. Which API manufacturers are most critical for gentamicin sulfate supply?
Wockhardt, Hikma, Zhejiang Hisun, and Rottapharm are the leading high-volume producers with worldwide regulatory approvals.

2. How does regulatory approval impact API supply?
Regulatory approval from agencies like US FDA or EMA ensures compliance with quality standards, facilitating global distribution and reducing supply delays.

3. Are regional suppliers sufficient for global demand?
Regional suppliers address local needs but generally lack the capacity for large-scale global supply, creating dependency on large international manufacturers.

4. What factors threaten the stability of gentamicin sulfate API supply?
Consolidation among API producers, geopolitical tensions, regulatory changes, and pandemic-related disruptions pose risks.

5. Can contract manufacturers fill supply gaps?
Yes, CMOs like Jubilant and Fareva can supplement supply, especially during shortages, but their capacity depends on client demand and regulatory approvals.

---

References

[1] U.S. Food and Drug Administration. (2022). API manufacturing standards and approvals. Retrieved from https://www.fda.gov/drugs/pharmaceutical-quality-resources/api-manufacturing-standards-and-approvals

[2] World Health Organization. (2021). WHO Good Manufacturing Practices (GMP) guidelines. Retrieved from https://www.who.int/medicines/areas/quality_safety/quality_assurance/gmp/en/

[3] European Medicines Agency. (2022). Regulations on Active Substance Manufacturing. Retrieved from https://www.ema.europa.eu/en/human-regulatory/overview/medicines/active-substances